Publication Date
| In 2024 | 0 |
| Since 2023 | 0 |
| Since 2020 (last 5 years) | 0 |
| Since 2015 (last 10 years) | 0 |
| Since 2005 (last 20 years) | 2 |
Descriptor
| Adolescents | 2 |
| Anxiety | 2 |
| Children | 2 |
| Drug Therapy | 2 |
| Pharmacology | 2 |
| Severity (of Disability) | 2 |
| Sleep | 2 |
| Correlation | 1 |
| Emotional Disturbances | 1 |
| Outcomes of Treatment | 1 |
| Rating Scales | 1 |
| More ▼ | |
Source
| Journal of the American… | 2 |
Author
| Ginsburg, Golda S. | 2 |
| Alfano, Candice A. | 1 |
| Davies, Mark | 1 |
| Kingery, Julie Newman | 1 |
| Riddle, Mark A. | 1 |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkAlfano, Candice A.; Ginsburg, Golda S.; Kingery, Julie Newman – Journal of the American Academy of Child and Adolescent Psychiatry, 2007
Objective: The present study examined sleep-related problems (SRPs) among a large sample (n = 128) of youth with anxiety disorders (i.e., generalized, separation, and social). The frequency of eight specific SRPs was examined in relation to age, gender, type of anxiety disorder, anxiety severity, and functional impairment. The impact of…
Descriptors: Severity (of Disability), Pharmacology, Adolescents, Anxiety
Ginsburg, Golda S.; Riddle, Mark A.; Davies, Mark – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To evaluate the prevalence of somatic symptoms (SSs) in children and adolescents with anxiety disorders; the relationship between SSs and anxiety severity, impairment, and child global functioning; and the impact of fluvoxamine (FLV) versus pill placebo (PBO) on reducing SSs. Method: As part of a double-blind, placebo-controlled trial,…
Descriptors: Severity (of Disability), Adolescents, Rating Scales, Anxiety
